Does PALBOCICLIB Cause Musculoskeletal stiffness? 287 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 287 reports of Musculoskeletal stiffness have been filed in association with PALBOCICLIB (Ibrance). This represents 0.3% of all adverse event reports for PALBOCICLIB.
287
Reports of Musculoskeletal stiffness with PALBOCICLIB
0.3%
of all PALBOCICLIB reports
10
Deaths
44
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From PALBOCICLIB?
Of the 287 reports, 10 (3.5%) resulted in death, 44 (15.3%) required hospitalization.
Is Musculoskeletal stiffness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 287 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which PALBOCICLIB Alternatives Have Lower Musculoskeletal stiffness Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID